{"id":"https://openalex.org/W3016846682","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.06003","title":"Discriminative Stimulus Effects of (R)(\u2212)\u2010DOI and AM8936, a Synthetic Cannabinoid","display_name":"Discriminative Stimulus Effects of (R)(\u2212)\u2010DOI and AM8936, a Synthetic Cannabinoid","publication_year":2020,"publication_date":"2020-04-01","ids":{"openalex":"https://openalex.org/W3016846682","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.06003","mag":"3016846682"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.2020.34.s1.06003","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.06003","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2020.34.s1.06003","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079503609","display_name":"Laura Lynn Erwin","orcid":"https://orcid.org/0000-0001-6638-6186","observed_orcids":["https://orcid.org/0000-0001-6638-6186"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Erwin","raw_affiliation_strings":["McLean Hospital/Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McLean Hospital/Harvard Medical School","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801148111"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061917163","display_name":"Spyros P. Nikas","orcid":"https://orcid.org/0000-0001-5052-5292","observed_orcids":["https://orcid.org/0000-0001-5052-5292"]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spyros Nikas","raw_affiliation_strings":["Northeastern University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northeastern University","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000540926","display_name":"Alexandros Makriyannis","orcid":"https://orcid.org/0000-0003-3272-3687","observed_orcids":["https://orcid.org/0000-0003-3272-3687"]},"institutions":[{"id":"https://openalex.org/I12912129","display_name":"Northeastern University","ror":"https://ror.org/04t5xt781","country_code":"US","type":"education","lineage":["https://openalex.org/I12912129"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Makriyannis","raw_affiliation_strings":["Northeastern University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northeastern University","institution_ids":["https://openalex.org/I12912129"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053275074","display_name":"Carol Anne Paronis","orcid":"https://orcid.org/0000-0002-3203-1966","observed_orcids":["https://orcid.org/0000-0002-3203-1966"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Paronis","raw_affiliation_strings":["McLean Hospital/Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McLean Hospital/Harvard Medical School","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801148111"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"S1","first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.3458999991416931,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.3458999991416931,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.3174000084400177,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.3086000084877014,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/synthetic-cannabinoids","display_name":"synthetic cannabinoids","score":0.9369999766349792},{"id":"https://openalex.org/keywords/discriminative-stimulus-effects","display_name":"discriminative stimulus effects","score":0.9049999713897705},{"id":"https://openalex.org/keywords/hallucinogenic-effects","display_name":"hallucinogenic effects","score":0.7279999852180481},{"id":"https://openalex.org/keywords/cb1-receptor-agonists","display_name":"CB1 receptor agonists","score":0.8169999718666077},{"id":"https://openalex.org/keywords/delta9-tetrahydrocannabinol","display_name":"delta-9-tetrahydrocannabinol","score":0.8880000114440918},{"id":"https://openalex.org/keywords/jwh-018","display_name":"JWH-018","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-substitution","display_name":"drug substitution","score":0.40700000524520874}],"concepts":[{"id":"https://openalex.org/C57022672","wikidata":"https://www.wikidata.org/wiki/Q7617378","display_name":"Stimulus control","level":3,"score":0.7597157955169678},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7255977392196655},{"id":"https://openalex.org/C2777846614","wikidata":"https://www.wikidata.org/wiki/Q19904200","display_name":"Synthetic cannabinoids","level":4,"score":0.6598453521728516},{"id":"https://openalex.org/C2780871563","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid","level":3,"score":0.6595888733863831},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5792300701141357},{"id":"https://openalex.org/C2910065304","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid Receptor Agonists","level":5,"score":0.539717972278595},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.48250675201416016},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.4560004770755768},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.43648409843444824},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4255702495574951},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.41222304105758667},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.4113757312297821},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4101770520210266},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.323424756526947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3085407018661499},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.20833158493041992},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19666236639022827},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.13223391771316528},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.08856475353240967}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.2020.34.s1.06003","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.06003","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2020.34.s1.06003","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2371740616","https://openalex.org/W2768174305","https://openalex.org/W2024706171","https://openalex.org/W2413677513","https://openalex.org/W2403085923","https://openalex.org/W2074141371","https://openalex.org/W2137036346","https://openalex.org/W2978202356","https://openalex.org/W3132385004","https://openalex.org/W2334189569"],"abstract_inverted_index":{"Increased":[0],"abuse":[1],"of":[2,23,43,56,89,181,246],"synthetic":[3,48],"cannabinoids":[4],"(SCBs)":[5],"continues":[6],"to":[7,72,227],"be":[8],"a":[9,45,85,249],"public":[10],"health":[11],"concern.":[12],"Preclinical":[13],"studies":[14,35,234],"have":[15,28],"identified":[16],"SCBs":[17,247],"as":[18],"being":[19],"THC\u2010like;":[20],"however,":[21],"occurrences":[22],"emesis,":[24],"hallucinations,":[25],"and":[26,65,94,124,139,161,248],"seizures":[27],"been":[29],"reported":[30],"with":[31],"their":[32,98,255],"usage.":[33],"These":[34,233],"examined":[36],"the":[37,40,52,59,107,145,206,242],"premise":[38],"that":[39,183,195,229,236],"hallucinogenic":[41],"effects":[42,55,245],"AM8936,":[44],"highly":[46],"potent":[47],"CB1":[49],"agonist,":[50,251],"resemble":[51],"discriminative":[53,243],"stimulus":[54,244],"another":[57],"hallucinogen,":[58],"5HT2A":[60],"agonist":[61,209],"(R)(\u2212)2,5\u2010dimethoxy\u20104\u2010iodoamphetamine":[62],"(DOI).":[63],"Male":[64],"female":[66],"Sprague\u2010Dawley":[67],"rats":[68],"(n=6/group)":[69],"were":[70,191],"trained":[71,96,109,147],"discriminate":[73],"either":[74],"0.18":[75,114],"mg/kg":[76,80],"AM8936":[77,95,111,140,146],"or":[78,223,259],"0.56":[79],"DOI":[81,93,108,149,182],"from":[82],"saline":[83],"under":[84],"shock":[86],"avoidance":[87],"schedule":[88],"reinforcement.":[90],"In":[91,106,144,204],"both":[92],"subjects,":[97,110,148],"respective":[99],"training":[100],"dose":[101],"produced":[102,130,141,167,176,184,230],"full":[103,142,177],"(>80%)":[104,178],"substitution.":[105,143,179],"(0.032":[112],"\u2013":[113,121,127,151,158,164,188,201,212],"mg/kg),":[115,123,160],"delta\u20109\u2010tetrahydrocannabinol":[116],"(\u0394":[117],"9":[118,155],"\u2010THC)":[119],"(1":[120,157,211],"10":[122,159,165,213],"JWH\u2010018":[125,138,162,175],"(0.1":[126,163,200],"3.2":[128,152,189],"mg/kg)":[129,166,190,214],"dose\u2010dependent":[131,168],"increases":[132,169],"in":[133,170,197,241,254],"DOI\u2010lever":[134,221],"responding,":[135,172],"but":[136,173],"only":[137,174],"(0.56":[150,187],"m/k),":[153],"\u0394":[154],"\u2010THC":[156],"AM8936\u2010lever":[171,224],"Doses":[180],"AM8936\u2010appropriate":[185],"responding":[186,199,222,225],"higher":[192],"than":[193,219],"those":[194],"resulted":[196],"DOI\u2010appropriate":[198],"0.8":[202],"mg/kg).":[203],"addition,":[205],"mu\u2010opioid":[207],"receptor":[208],"morphine":[210],"(negative":[215],"control)":[216],"engendered":[217],"less":[218],"20%":[220],"up":[226],"doses":[228],"behavioral":[231],"disruption.":[232],"indicate":[235],"there":[237],"is":[238],"bi\u2010directional":[239],"overlap":[240],"5\u2010HT2A":[250],"suggesting":[252],"similarities":[253],"subjective":[256],"effects.":[257],"Support":[258],"Funding":[260],"Information":[261],"Acknowledgements":[262],"Funded":[263],"by":[264],"NIH/NIDA:":[265],"DA043700":[266]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2020-04-24T00:00:00"}